Clinical Trials in CNS

-

The SMi Group is proud to present their 11th annual Clinical Trials in CNS conference that will discuss the latest developments in preclinical discovery, clinical trial design, clinical trial management and the latest developments in neurodegenerative treatments.

Key reasons to attend:

• Learn of the latest drug developments combating the key diseases in CNS, from Alzheimer's and dementia, to depression and schizophrenia
• Discuss the cutting issues of the industry, from the ethics of outsourcing, to proving efficacy
• Explore the latest innovations in pre-clinical discovery, trial optimisation and biomarker identification
• Discover new ways to manage and adapt a clinical trial to ensure its success and efficiency
• Network with key members of the industry involved in every part of clinical trials: from bench to bedside

Key Speakers Include:

• Johan Luthman, Senior Programme Leader, Merck & Co.
• Florian Von Raison, Global Program Head, Novartis
• Michael O’Neill, Senior Research Advisor, Eli Lilly
• Bruno Pitrosky, Global Program Lead, Primary Care, Pfizer PGRD
• Lars Bauer, Senior Medical Director, TA CNS, UCB Biosciences GmbH
• Frank Miller, Senior Statistician and Principal Scientist, AstraZeneca

Register at http://www.smi-online.co.uk/goto/clinicaltrials-research20.asp
Alternatively contact Fateja Begum on tel: +44 (0) 20 7827 6184 or email: fbegum@smi-online.co.uk


Location:
Copthorne Tara Hotel, London
Scarsdale Place,
Kensington,
Kensington & Chelsea,
London,
W8 5SR
UK


Organizer: SMi Group Ltd

5 Nov 2012

Upcoming Featured Events
1 2 Next 
Neuroscience 201711 Nov 2017
SLAS20183 Feb 2018
Pittcon Conference and Expo 201826 Feb 2018
analytica 201810 Apr 2018
AACR ANNUAL MEETING 201814 Apr 2018
66th ASMS Conference3 Jun 2018
ACHEMA 201811 Jun 2018
70th AACC Annual Scientific Meeting & Clinical Lab Expo29 Jul 2018



Advertisement

Advertisement

Advertisement